Marcel Reiser

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)

Michael Pfreundschuh, Jöerg Schubert, Marita Ziepert et al. · The Lancet Oncology · 2008 · 1.1K citations

Hematological Malignancy, Lymphoid Neoplasia, Elderly Patients +7

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

Eva Hoster, Martin Dreyling, Wolfram Klapper et al. · Blood · 2007 · 944 citations

Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma

A. Herrmann, Eva Hoster, Thomas Zwingers et al. · Journal of Clinical Oncology · 2008 · 394 citations · Full text

The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL

Carsten Müller, Niels Murawski, Martin H. J. Wiesen et al. · Blood · 2012 · 233 citations · Full text

Time-intensified dexamethasone/cisplatin/cytarabine:an effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin’s disease

Andreas Josting, Christian Rudolph, Marcel Reiser et al. · Annals of Oncology · 2002 · 219 citations · Full text

Refractory Hodgkin ’, Lymphoid Neoplasia, Low Toxicity +7